Background: Inflammatory bowel disease (IBD) affects the quality of patients' life in many ways. The aim of this study was to develop and validate
I
nflammatory bowel diseases (IBD) consisting of ulcerative colitis (UC) and Crohn's disease (CD) are incurable inflammatory disorders of the gastrointestinal tract with unknown etiology. 1 The major symptoms of IBD are abdominal pain, diarrhea, rectal bleeding, weight loss, and fever. The incidence of IBD in China was considered to be lower than in the Western countries, but it has been increasing rapidly in recent years with the Westernization of diet and lifestyle, and economic development. 2 Currently, IBD has become one of the most common diseases of the gastrointestinal system in China. 3 IBD usually occurs at young age. Following a relapsing and remitting course, it affects patients in many ways, including career, social lives, and family lives. [4] [5] [6] The conventional clinical indices, such as laboratory measurements and endoscopic and disease activity indices are considered powerful to assess the physiological and pathological changes in the IBD. However, these methods cannot fully estimate the impact of the disease on patients' everyday lives. 7 Health-related quality of life (HRQOL) refers to the patients' subjective perceptions of illness, the impacts on daily life and the physical, mental and social aspects of well-being. 8 Instruments used to measure HRQOL can be divided into generic or disease-specific ones. Compared with the former, the latter focuses on a certain disease group or function group and is believed to be more responsive to changes. 9 The McMaster IBD questionnaire developed by Irvine et al 10 is one of these diseasespecific questionnaires and is used widely as an instrument to assess the quality of life (QOL) of patients with IBD. [11] [12] [13] [14] [15] [16] [17] It was translated and validated in Mainland China 10 years ago. 16 Although the Mainland Chinese IBD questionnaire (MCIBDQ) has been initially proved to be a valid and reliable instrument for assessing QOL in patients with IBD, 16 its copyright restriction, relatively expensive copyright fee, and a complex process to obtain permission all limited its wide use in Mainland China. This is consistent with our literature review, which shows only a few applications of the questionnaire in Mainland China since its validation. The fact that China funded more on basic research instead of clinical research exacerbated this situation. 18 Because of the increasing number of patients with IBD in China, it is necessary to carry out more research on QOL of this population. We anticipated a pressing need to have another instrument available to serve this purpose. In addition, some Chinese patients with IBD who had the experience of filling out the MCIBDQ informed us that they personally considered some response options of the questionnaire a bit ambiguous and complex, also the expressions of some questions not colloquial enough. This further indicates a need to develop a local questionnaire in China. Therefore, the aim of this study was to develop and validate a Mainland Chinese version of IBD QOL questionnaire (IBDQOL) with independent copyright for UC and CD by assessing its validity, discriminant ability, reliability, and sensitivity to change.
MATERIALS AND METHODS
The study was composed of 2 phases: development of the draft IBDQOL and validation of the IBDQOL.
Development Phase

Item Generation
A descriptive qualitative research 19, 20 was used to explore the illness experiences of patients living with IBD in Mainland China and its impacts on their life. Purposive sampling was used to select information-rich participants with an established IBD diagnosis of no less than 6 months. Semistructured interviews were conducted with participants in clinics or wards. The interview questions were open and broad and as follows: Tell me your illness experiences since being diagnosed as IBD? Tell me the impacts of IBD on your life? Tell me your experience when your IBD were in a state of remission? Tell me your experience when your IBD were in a state of relapse? Follow-up questions were used to encourage the elaboration of responses when necessary and probing questions were used to ensure clarity. As a result of ongoing analysis, the interview format became more structured. All the interviews were audio-recorded and transcribed verbatim.
Conventional content analysis was used to analyze data through systematic process of coding. The generated codes were grouped together based on similarity and they were used to develop an initial list of possible items. 21 The words and phrases used by interview participants were retained wherever possible. When saturation reached, which means gathering more data added nothing new to the themes, 22 literature review about QOL of IBD patients was started to add more items to the list. After that, an initial pool of items was developed for inclusion in the questionnaire.
Item Reduction
A convenience sample of 21 patients with IBD and 12 IBD clinicians was invited to rate the perceived importance of the initial pool of items using a 5-point Likert scale (from 1 not very important to 5 extremely important). They were also asked to comment on the content and relevance of these items. Items considered relatively unimportant, redundant, or ambiguous were deleted based on the ranking results, comments, and our clinical experience.
Pretesting of the IBDQOL
To guarantee the ease of completion and clarity of IBDQOL, 5 patients with IBD and 8 IBD clinicians were invited to evaluate the wording clarity, use of response options, ordering of items, and layout of the questionnaire. A 5-point Likert scale and a 7-point Likert scale were offered for comparison and comments. A draft questionnaire was produced for validation after that.
Validation Phase
The psychometric properties of the draft IBDQOL were evaluated by assessing its validity, discriminant ability, reliability, and sensitivity to change in patients with IBD in Mainland China.
Patients
From June 2014 to February 2016, a convenient sample of patients with IBD was recruited from outpatient department and inpatient department of 7 hospitals in 3 provinces (Zhejiang, Jiangsu, and Guangdong) in southeast China.
The inclusion criteria were as follows: (1) an established diagnosis of UC or CD according to the Lennard-Jones criteria 23 ; (2) a disease duration of no less than 6 months; and (3) age at least 18 years. Patients who were unable to comprehend or complete the questionnaire and those with presence of other conditions, which might influence their QOL apparently, such as a stoma, psychiatric disorder or malignancy, were excluded.
Measurements
IBD Qualify-of-Life. The draft questionnaire produced from the development phase was used. Each item was scored on a 5-point Likert scale, ranging from 1 (represents a very severe problem) to 5 (represents no problem at all), reflecting the QOL of patients with IBD in the previous 2 weeks. A higher score indicates a better QOL. Participants were asked to complete the IBDQOL twice, at an interval of 2 weeks to 2 months. On completion, a research nurse interviewed the patients and any difficulties encountered with the questionnaire were discussed.
36-Item Short Form Health Survey. HRQOL was also evaluated using a widely used generic QOL measure, the 36-Item Short Form Health Survey (SF-36). The SF-36 has been validated and used in various medical conditions [24] [25] [26] [27] in Mainland China, including gastrointestinal disease. 28 It assesses 8 dimensions of QOL, namely physical functioning (PF), role limitations because of physical health problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations because of emotional problems (RE), and mental health (MH). The dimensions of PF, RP, BP and GH form the physical health component and the dimensions of VT, SF, RE and MH the mental health component. 29 A higher score indicates a better health status.
Disease activity indices. Disease activity was measured by 2 scales. In patients with UC, the Walmsley simple colitis activity index 30 was used. It includes bowel frequency during the day and night, urgency of defecation, blood in stool, general well-being, and extra-colonic features. Its total score ranges from 0 to above 16. In patients with CD, the Harvey-Bradshaw simple index 31 was used. It includes general well-being, abdominal pain, number of liquid stools per day, abdominal mass, and complications. Its total score ranges from 0 to above 12. These 2 scales were chosen because they depend fully on symptoms, and do not need any invasive procedures, yet they have correlated very well with the more complex ones. 30, 31 Disease activity indices were scored after the participants completed the IBDQOL on both occasions.
Statistical Analysis
SPSS statistical package v.17.0 (Chicago, IL) was used for all statistical analysis. Mean, median, range and frequency were used to describe the demographic and clinical characteristics. To determine whether the scores of the IBDQOL might differ between patients with UC and CD, validity, discriminant ability, reliability, and sensitivity to change were analyzed separately for these 2 conditions. For all analyses, statistical significance was set at 0.05, 2-sided.
Construct Validity
Construct validity indicates the degree to which a test measures what it is proposed to measure. Two approaches were used to assess the construct validity of the IBDQOL: exploratory factor analysis and Pearson correlation coefficient. An exploratory factor analysis (principal components, orthogonal varimax rotation, and scree plot for selecting the number of factors) was performed to produce underlying factor structures. Items with loading above 0.4, cross-loadings greater than 0.15 were considered contributing to the IBDQOL and would be included. 32 Pearson correlation coefficient was used to examine the hypothesized correlations between the IBDQOL, SF-36, and disease activity. The hypotheses are presented as below: (1) Depending on the factors generated, they would be compared, if determined to measure similar constructs, with similar SF-36 dimensions. (2) The IBDQOL total score had a high correlation with the physical component summary score and the mental component summary score of the SF-36. (3) The IBDQOL total scores had a moderate correlation with disease activity indices.
Discriminant Ability
Discriminant ability examines the ability to distinguish between groups that are expected to differ regarding the variable evaluated. In this study, patients were divided into 2 groups: active (a disease activity score equal to or greater than 4) or remission (a disease activity score less than 4). An independent t-test was used to investigate whether the IBDQOL was able to discriminate between patients in remission group and active group.
Reliability
The reliability of the questionnaire was measured by internal consistency and test-retest reliability. The internal consistency was assessed by Cronbach's alpha, with a result above 0.7 indicating adequate consistency. 33 The test-retest reliability was assessed by intraclass correlations coefficient (ICC). An ICC . 0.4 was considered as acceptable, an ICC . 0.6 was considered as satisfactory, and an ICC . 0.8 was considered as excellent. 34 
Sensitivity to Change
Sensitivity to change refers to the ability to detect changes over time. In this study, it was estimated by comparing the IBDQOL scores between the 2 occasions for patients who reported more than one-point change of disease activity index. A paired t-test was used to estimate the sensitivity to change. 
ETHICAL CONSIDERATIONS
The ethics committee of Zhejiang Chinese Medical University approved the study. Confidentiality of patient information and records was ensured. All participants gave their written informed consents.
RESULTS
Development Phase
Forty-seven patients (18 UC and 29 CD) with mild to severe disease from 2 level 3 teaching hospitals in Zhejiang Province participated in the interview between July 2013 and January 2014. There were 26 (55%) males, and the mean age was 36.6 years old (SD ¼ 10.8, range 23-67). The median of disease duration was 38 months and the interquartile range was 11 to 57.
Most of them had received secondary education (n ¼ 22) and tertiary education or above (n ¼ 22), 3 had received primary education or under. Eight were single and 39 were married. When being interviewed, 20 patients were in active and 27 were in remission. And 35 continued to work or study, 7 were unemployed and 5 were retired. Each interview lasted from 10 to 90 minutes. Based on content analysis results and literature review, an initial pool of 51 items was generated.
Twenty-one IBD patients (7 UC and 14 CD) and 12 IBD clinicians (7 nurses and 5 doctors) took part in the item reduction survey. These IBD patients were all recruited from the outpatient department in one large teaching hospital in Zhejiang Province. Among them, 14 (66.7%) were male and the mean ages was 35.6 years old with a range from 24 to 59. The median of disease duration was 60 months and the interquartile range was 20 to 86. 
Validation Phase
Three hundred and thirty-six Chinese IBD patients participated in the validation phase (128 UC patients and 208 CD patients). Two hundred and twenty-seven patients were recruited from outpatient department and 107 were hospitalized at the initial completion of the questionnaire. The demographic and clinical data of participants were listed in Table 1 . There were 204 (60.7%) males, and the mean age of participants was 35.9 years (SD ¼ 12.4, range 18-81). The median disease duration was 36 months and the interquartile range was 12 to 72. Mean disease activity indices were 2.9 and 2.4 for UC and CD patients respectively. One hundred and thirty-nine patients completed the questionnaire a second time at a mean interval of 44 days following the initial completion. Forty-one of these patients remained stable and 56 showed more than one-point change of disease activity index.
Construct Validity
The Kaiser-Meyer-Olkin index was 0.928 and the Bartlett's test of sphericity had statistics significance (P , 0.001). A factor was considered important if its "eigenvalue" exceeded 1.0. As a result, 4 factors were yielded which explained 52.81% of the variance. These factors were named as social function, emotional function, symptoms and discomfort, bowel symptoms and its influences (Table 2) . Eight items were removed from the draft questionnaire because of failing to load above 0.4 on any factor (n ¼ 2) or a cross-loading less than 0.15 (n ¼ 6). Finally, a questionnaire containing 22 items was developed.
Based on the factor analysis result, hypotheses between factors of the IBDQOL-22 and the SF-36 dimensions which measured similar constructs, were put forwarded as below. 
Discriminant Ability
Both UC and CD patients who were in the remission group (disease activity indices: colitis activity index or Harvey-Bradshaw simple index , 4) had significantly higher mean domain scores of the IBDQOL-22 than those who were in the active group (disease activity indices: colitis activity index or Harvey-Bradshaw simple index $ 4) (P , 0.01) ( Table 5 ).
Internal Consistency
The Cronbach's alpha for the IBDQOL-22 was 0.93 in patients with UC and 0.89 in patients with CD. Good internal reliability was also confirmed for the 4 domains of the IBDQOL-22 with a range of 0.77 to 0.90 in patients with UC and 0.76 to 0.89 in patients with CD.
Test-retest Reliability
According to disease activity index, 41 patients (17 patients with UC and 24 patients with UC) remained stable between the first and second occasions of completing the questionnaire. Table 6 presents the test-retest reliability result. We found that the ICC were both good in patients with UC (range from 0.87 to 0.96) and CD (range from 0.72 to 0.90).
Sensitivity to Change
Fifty-six patients (16 with UC and 40 with CD) whose disease activity index had changed more than one point between the initial and the second occasions were included in the sensitivity analysis. For patients with UC, 16 improved and 0 deteriorated. For patients with CD, 28 improved and 12 deteriorated. The mean score change for the disease activity index was 3.77 6 1.97. The results of the paired t-test are shown in Table 7 . Statistically significant differences between baseline and follow-up were found in emotional function, symptoms and discomfort, and bowel symptoms and its influence domains of both UC and CD patients.
DISCUSSION
IBD is a chronic disease that has a significant influence on patients' QOL. HRQOL measurement not only plays an important role in clinical trials of patients with IBD, but also in the therapeutic management of the diseases. 35, 36 It is necessary to develop instruments to assess the QOL of Chinese patients with IBD.
A descriptive qualitative research was used to generate the items of the IBDQOL-22. This stage served as a vehicle for us to understand the impact of IBD on patient's life, and also gave us Because there were no previous assumptions about how many factors would be extracted and no expectations of which item would be load on which factor, an exploratory factor analysis was used to test construct validity. Sample size for exploratory factor analysis is determined by item ratios of 1:10 or less. 37 The large sample size (n ¼ 336) in this study makes it suitable for this analysis. The result presented a "cleanest" factor structure, with item loading above 0.4, few item cross-loading, and no factors with fewer than 3 items. 37 The item contents of the 4 factors were interpreted rigorously and an appropriate name was given to each factor.
Pearson correlation coefficient showed moderate or high relationship between the IBDQOL-22 domain scores and the related SF-36 dimensional scores, the physical component or the mental component summary score of the SF-36; between the total IBDQOL-22 score and the physical component or the mental component summary score of the SF-36 or disease activity index in both UC and CD patients. Despite this, 2 weak relationships were found. The bowel symptoms and its influences domain of the IBDQOL-22 correlated less well with the physical component summary score (r ¼ 0.36) and mental component summary score (r ¼ 0.33) in patients with CD. These might be due to few items of the physical health or mental health component of the SF-36 specifically assessing bowel symptoms and its influences of an individual. The other was that the emotional function domain of the IBDQOL-22 correlated less well with disease activity indices (r ¼ 20.22) in patients with CD. We considered this might be related to the fact that disease activity index only assesses physical dimension. Even in remission, patients with CD might still have emotional problems such as anxiety, worry, or frustration. 4 The IBDQOL-22 taps into factors other than bowel symptoms and is therefore complementary to disease activity indices. Future studies could be conducted to further explore this phenomenon. Discriminant ability was tested and the IBDQOL-22 was able to discriminate between patients with active disease and those who were in remission. Reliability was assessed by the internal consistency and test-retest reliability. The results suggested that the IBDQOL-22 had excellent internal consistency and high reproducibility for patients with UC and CD, respectively. This suggested that the questionnaire could be used for measuring change in QOL over time.
Sensitivity to change showed that all domains of the IBDQOL-22 differed significantly with the exception of the social function domain in both patients with UC and CD. The lack of sensitivity in the social function domain has also been found in other similar studies. 12, 16, 38 It could be because at the time of enrollment, most patients were in remission or had merely mild active disease, their social function might not have been influenced to a great extent. It was possible that having a chronic disease, these patients might have lowered their expectation of social function or gradually adapted to their changed daily lives. 39 In addition, it could also be related to the small sample size, especially in the group with patients with UC (n ¼ 16). For this reason, sensitivity to change of the IBDQOL-22 needs further test in large samples in future.
The Mainland Chinese version of IBD (MCIBDQ) translated from the original English version (Dr. Jan Irvine of McMaster University) has been validated previously. 16 Compared with the MCIBDQ, the IBDQOL-22 has some advantages concerning the response options and the content. Many Chinese patients with IBD indicated that the 7-point response options were too complex and some of them were a bit ambiguous. It was a little hard for them to discriminate between the 7 options. This phenomenon was also reported in a previous published article on developing and validating a U.K. version of the McMaster IBD questionnaire. 17 By contrast, the IBDQOL-22 was graded on a 5-point Likert scale. Apparently, it was not only easy to choose, but also more colloquial and understandable for the participants. The content of the questions in the IBDQOL-22 was also more suitable for Chinese context. Six questions regarding passing gas, energy level, body weight, emotion, and degree of overall satisfaction in the MCIBDQ were removed in the IBDQOL-22 based on exploratory factor analysis. Two questions not included in the MCIBDQ were present in the IBDQOL-22. One was item 15: "To what extent have you felt worried about the possibility of your child/children inherited your bowel problem?" Probably this was due to the one child policy implemented from 1979 to 2016 in China, which means most time a couple could only have a child and this made them much eager to have a healthy one. The other was item 21: "To what extent has your bowel problem affected your function at home or at work?" It was possible that China is a country with collectivist cultures, Chinese people center on collectives (e.g., families, work units, and nations), and much of the goals of individuals are consistent with the goals of these collectives. 40 So they really care about the impacts of IBD on their family and jobs. Because of these advantages, we considered the IBDQOL-22 as more appropriate to use in patients with IBD in Mainland China than the previous MCIBDQ.
Despite this advantage, some limitations of this study should be noted. First of all, the sample size for the sensitivity to change analysis of the IBDQOL-22 was small, especially in patients with UC. Further studies with larger sample size are required. Second, the 4 factors explained 52.81% of the variance in total, although this was acceptable, 41 it indicates that around 47% of the construct assessed by the scale was not captured by the included items. Although the instrument developed and validated here is a good start, more psychometric evaluations are needed to recommend it as a reliable and valid instrument.
In conclusion, the IBDQOL-22 is developed with rigorous method and seems to be a valid and reliable instrument for assessing the QOL of patients with IBD in Chinese mainland. It is recommended for use in daily clinical practice and scientific research to measure the effects of interventions for patients with IBD. In future, QOL measurements targeted at perianal diseases or stoma for Chinese patients with IBD could also be developed.
